CEO, Clinical RD Consulting, LLC - Feb 2015 to Present
CEO, Pulmotect, Inc Jan 2017-Feb 2018
Chief Medical Officer at KaloBios Pharmaceuticals from 2012 to 2015
VP Respiratory at MedImmune from 2007 to 2012
Sr Director Respiratory at Otsuka Maryland Research Institute from 2003 to 2007
Director Vaccines at Baxter from 2001 to 2003
VP R&D at Theratechnologies from 1997 to 2001
Director at Abbott from 1996 to 1997
Director at BI from 1994 to 1996
24-year contributions summary
- Different degrees of responsibility in strategy and execution in severe respiratory conditions : anti-GMCSF, IL5r, IL9 and IL13 antibodies in asthma , anti -Pa in CF, respiratory infections, PDE4 inhibitors and anti-IL5r in COPD as well as anti IL13 in IPF.
- Team member in VAP strategies, anti RSV and flu vaccines, inhaled therapies for asthma and COPD and antibiotics to URTI and CAP
- Part of the Executive team who took Kalobios public in Jan 2013 and raised series B for Pulmotect, Inc.
- Have organized, chaired and participated in a number of scientific advisory boards in the above mentioned programs
Website last updated August, 2016